Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2.
Jeong D, Kim HS, Kim HY, Kang MJ, Jung H, Oh Y, Kim D, Koh J, Cho SY, Jeon YK, Lee EB, Lee SH, Shin EC, Kim HM, Yi EC, Chung DH.
Elife. 2021 Jul 5;10:e48840. doi: 10.7554/eLife.48840.PMID: 34223817
https://pubmed.ncbi.nlm.nih.gov/34223817/